Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 239

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 239
---
 the required notice, and the copy of Section 262 of the DGCL is attached to this Proxy Statement/Prospectus as Annex E. A holder of Enfusion Common Stock who wishes to exercise appraisal rights or who wishes to preserve the right to do so should review the following discussion and Annex Ecarefully and consult with legal advisors. Failure to strictly comply with the procedures of Section 262 of the DGCL in a timely and proper manner may result in the loss of appraisal rights under the DGCL. A stockholder or beneficial owner who loses his, her or its appraisal rights will be entitled to receive the Merger Consideration. How to Exercise and Perfect Your Appraisal Rights.Enfusion Stockholders and beneficial owners wishing to exercise the rights to seek an appraisal of their shares must do ALL of the following:

| • |     | you must not vote in favor of approval of the Merger Agreement Proposal. Because a proxy that is signed and                                                                                                                                              
 submitted but does not otherwise contain voting instructions will, unless revoked, be voted in favor of approval of the Merger Agreement Proposal, if you submit a proxy and wish to exercise your appraisal rights, you must instruct the proxy to vote 
 your shares against approval of the Merger Agreement Proposal or abstain from voting your shares on the approval of the Merger Agreement Proposal;                                                                                                       |

| • |     | you must deliver to Enfusion a written demand for appraisal before the vote on the approval of the Merger                                
 Agreement Proposal at the Special Meeting and be a stockholder of record or a beneficial owner at the time of the making of such demand; |

| • |     | you must continuously hold (or, in the case of beneficial owners, beneficially own) the shares from the date of 
 making the demand through the Effective Time; and                                                               |

| • |     | you, any other stockholder or beneficial owner that is entitled to and has properly demanded appraisal rights or                                                                                
 the Surviving Corporation in the Merger (or, if completed, the Second Merger) must file a petition in the Delaware Court of Chancery requesting a determination of the fair value of the shares |

170

| within 120 days after the Effective Time. The Surviving Corporation is under no obligation to file any such petition in the Delaware Court of Chancery and has no intention of doing so.                                                           
 Accordingly, it is the obligation of the Enfusion Stockholders and beneficial owners to initiate all necessary action to perfect their appraisal rights in respect of shares of Enfusion Common Stock within